NCT04955431

Brief Summary

Particulate matter exposure during smoke inhalation provokes inflammatory immune responses in people exposed to burning biomass including fire fighters and civilians. Persistent occupational exposure to particulate matter represents a unique hazard for firefighters, underpinning a burgeoning research area. This trial will evaluate the effects of sleep deprivation and circadian rhythm disruption on the inflammatory response to woodsmoke associated particulate matter exposure. Participants will undergo 2 experimental trials in a randomized cross-over design. Participants will have either an 8-hour sleep opportunity or a 4-hour sleep opportunity prior to reporting to lab for a 45 minute simulated firefighting trial (wood smoke associated particulate matter filtered to 2.5 um at a concentration of 250 ug/m\^3, while exercising at a moderate intensity). The effects of sleep restriction and simulated firefighting will be measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 21, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 8, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

January 24, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2022

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

May 30, 2025

Completed
Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

2 months

First QC Date

June 21, 2021

Results QC Date

April 6, 2023

Last Update Submit

May 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood Inflammation

    IL-6 will be measured in the plasma

    samples collected at baseline, immediately post exposure

Secondary Outcomes (1)

  • Exhaled Breath Condensate Pentraxin-3

    samples collected at baseline, immediately post exposure

Study Arms (2)

Normal Sleep (with 250 ug/m^3 PM2.5)

PLACEBO COMPARATOR

Participants will have a normal sleep opportunity the night prior to reporting to the lab for the simulated firefighting session (250 ug/m\^3 PM2.5 with moderate intensity exercise).

Behavioral: Normal Sleep

Restricted Sleep (with 250 ug/m^3 PM2.5)

EXPERIMENTAL

Participants will have a restricted sleep opportunity (\~4 hours) the night prior to reporting to the lab for the simulated firefighting session (250 ug/m\^3 PM2.5 with moderate intensity exercise).

Behavioral: Sleep Restriction

Interventions

Participants will be allowed \~4 hour sleep opportunity during the restricted night of sleep prior to reporting to lab for a simulated firefighting session.

Also known as: Circadian Rhythm Disruption, SR
Restricted Sleep (with 250 ug/m^3 PM2.5)
Normal SleepBEHAVIORAL

Participants will be allowed \~8 hour sleep opportunity the night of sleep prior to reporting to lab for a simulated firefighting session.

Also known as: NS
Normal Sleep (with 250 ug/m^3 PM2.5)

Eligibility Criteria

Age18 Years - 44 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Male
  • years of age

You may not qualify if:

  • Preexisting cardiometabolic and/or pulmonary diseases
  • Preexisting sleep disorder
  • Smoking (current or within last year)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Integrative Physiology and Athletic Training

Missoula, Montana, 59812, United States

Location

MeSH Terms

Conditions

InflammationSleep DeprivationSleep Disorders, Circadian RhythmSmoke Inhalation Injury

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsDyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsMental DisordersChronobiology DisordersOccupational DiseasesBurns, InhalationBurnsWounds and Injuries

Limitations and Caveats

Our study was limited by a smaller sample size than we had anticipated.

Results Point of Contact

Title
Dr. John Quindry
Organization
University of Montana

Study Officials

  • John C Quindry, PhD

    University of Montana

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized cross-over design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair

Study Record Dates

First Submitted

June 21, 2021

First Posted

July 8, 2021

Study Start

January 24, 2022

Primary Completion

March 17, 2022

Study Completion

April 17, 2022

Last Updated

May 30, 2025

Results First Posted

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared with other researchers. Blinded anonymized outcomes data will be shared via publication and presentation of results.

Locations